Close Menu

NEW YORK – Laboratory Corporation of America said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for an RNA extraction method for use in SARS-CoV-2 testing.

According to the Burlington, North Carolina-based company, the method uses heat to trap viral particles, which eliminates the need to use RNA extraction reagents to capture viral nucleic acid for testing, improving turnaround time and reducing reliance on extraction reagents, which have proved a supply chain bottleneck at points in the pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

Nov
10
Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.